Fosun Pharma and Lonza to Start Generic Drug JV

Shanghai Fosun Pharmaceutical (Group) and Lonza Group of Switzerland will form a generic drug JV with 100 million RMB ($15.6 million) in capital. The JV will take advantage of the strengths of each parent: Lonza in APIs and intermediates; Fosun in finishing and China distribution. The JV will be owned equally by the two partners. More details.... Stock Symbols: (SHE: 600196) (VTX: LONN) Share this with colleagues:   var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});